Korean Circ J.  2020 Nov;50(11):974-983. 10.4070/kcj.2020.0283.

Consensus Statement on Coronary Intervention during the Coronavirus Disease 2019 (COVID-19) Pandemic: from the Korean Society of Interventional Cardiology (KSIC)

• Lee KY
• Lee BK
• Kim WJ
• Kang SH
• Park TK
• Kim SY
• Suh JW
• Yoon CH
• Yang DH
• Ryu SK
• Kim SH
• Lee SY
• Chae IH
• The Korean Society of Interventional Cardiology COVID-19 Task Force Team

• KMID: 2508280
• DOI: http://doi.org/10.4070/kcj.2020.0283

Abstract

Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by the novel virus severe acute respiratory syndrome coronavirus-2. The first case developed in December, 2019 in Wuhan, China; several months later, COVID-19 has become pandemic, and there is no end in sight. This disaster is also causing serious health problems in the area of cardiovascular intervention. In response, the Korean Society of Interventional Cardiology formed a COVID-19 task force to develop practice guidelines. This special article introduces clinical practice guidelines to prevent secondary transmission of COVID-19 within facilities; the guidelines were developed to protect patients and healthcare workers from this highly contagious virus. We hope these guidelines help healthcare workers and cardiovascular disease patients around the world cope with the COVID-19 pandemic.

Keyword

COVID-19; Cardiovascular diseases; Coronary angiography; Percutaneous coronary intervention; Practice guideline

Figure

• 

  Figure 1 Composition of personal protective equipment by role.

• 

  Figure 2 The donning and doffing of level D personal protective equipment (from Korea Centers for Disease Control and Prevention modified).

• 

  Figure 3 Proposed management algorithm for STEMI patients.Cath Lab = catheterization laboratory; COVID-19 = coronavirus disease 2019; ECG = electrocardiogram; HEPA = high-efficiency particulate air; ICU = intensive care unit; MI = myocardial infarction; PCI = percutaneous coronary intervention; PPE = personal protective equipment; STEMI = ST-segment elevation myocardial infarction.*Contraindication to thrombolytics: any previous history of hemorrhagic shock, ischemic stroke within 3 months, head trauma within 3 weeks or brain surgery within 6 months, known intracranial neoplasm, suspected aortic dissection, internal bleeding within 6 weeks, active bleeding or known bleeding disorder, traumatic cardiopulmonary resuscitation within 3 weeks. †High risk features: cardiogenic shock, life threatening arrhythmias, severe pulmonary edema, and large ischemic burden MI (e.g. anterior location).

• 

  Figure 4 Proposed management algorithm for NSTE-ACS patients.COVID-19 = coronavirus disease 2019; ICU = intensive care unit; MI = myocardial infarction; NSTE-ACS = non-ST-segment elevation acute coronary syndrome; PCI = percutaneous coronary intervention.*High risk features: cardiogenic shock, life-threatening arrhythmias, severe pulmonary edema, and large ischemic burden MI (e.g. anterior location).

• 

  Figure 5 Triage of patients with cardiovascular disease requiring cardiovascular interventions.AS = aortic stenosis; CAD = coronary artery disease; Cath Lab = catheterization laboratory; MI = myocardial infarction; MR = mitral regurgitation; NSTE-ACS = non-ST-segment elevation acute coronary syndrome; NYHA = New York Heart Association.

Reference

1. Choe PG, Kang EK, Lee SY, et al. Selecting coronavirus disease 2019 patients with negligible risk of progression: early experience from non-hospital isolation facility in Korea. Korean J Intern Med. 2020; 35:765–770. PMID: 32460457.

2. Korea Centers for Disease Control and Prevention. The 8th update of COVID-19 response guideline [Internet]. Cheongju: Korea Centers for Disease Control and Prevention;2020. cited 2020 May 29. Available from http://www.cdc.go.kr/board.es?mid=a20507020000&bid=0019&act=view&list_no=367193.

3. Korea Centers for Disease Control and Prevention. Steps to put on and take off level D personal protective equipment [Internet]. Cheongju: Korea Centers for Disease Control and Prevention;2020. cited 2020 May 29. Available from http://www.cdc.go.kr/gallery.es?mid=a20503020000&bid=0003&act=view&list_no=136756.

4. Lemkes JS, Janssens GN, van der Hoeven NW, et al. Coronary angiography after cardiac arrest without ST-segment elevation. N Engl J Med. 2019; 380:1397–1407. PMID: 30883057.

5. Rab T, Kern KB, Tamis-Holland JE, et al. Cardiac arrest: a treatment algorithm for emergent invasive cardiac procedures in the resuscitated comatose patient. J Am Coll Cardiol. 2015; 66:62–73. PMID: 26139060.

6. Welt FGP, Shah PB, Aronow HD, et al. Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: from the ACC's interventional council and SCAI. J Am Coll Cardiol. 2020; 75:2372–2375. PMID: 32199938.

7. Galeazzi GL, Loffi M, Di Tano G, Danzi GB. Severe COVID-19 pneumonia and very late stent thrombosis: a trigger or innocent bystander? Korean Circ J. 2020; 50:632–633. PMID: 32588573.

8. Campo G, Rapezzi C, Tavazzi L, Ferrari R. Priorities for Cath labs in the COVID-19 tsunami. Eur Heart J. 2020; 41:1784–1785. PMID: 32286606.

9. Armstrong PW, Gershlick AH, Goldstein P, et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med. 2013; 368:1379–1387. PMID: 23473396.

10. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323:1061–1069. PMID: 32031570.

11. Deng Q, Hu B, Zhang Y, et al. Suspected myocardial injury in patients with COVID-19: evidence from front-line clinical observation in Wuhan, China. Int J Cardiol. 2020; 311:116–121. PMID: 32291207.

12. Zeng JH, Liu YX, Yuan J, et al. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection. 2020.

13. Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol. 2020; 31:1003–1008. PMID: 32270559.

14. Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association? Eur Heart J. 2020; 41:1858. PMID: 32227120.

15. Klok FA, Kruip MJ, van der Meer NJ, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; 191:145–147. PMID: 32291094.

16. Shah PB, Welt FGP, Mahmud E, Phillips A, Anwaruddin S. Reply: triage considerations for patients referred for structural heart disease intervention during the coronavirus disease 2019 (COVID-19) pandemic: an ACC/SCAI consensus statement. JACC Cardiovasc Interv. 2020; 13:1607–1608. PMID: 32646705.